REQUEST A DEMO
Total
USD $0.00
Search more companies

G.L. Pharma Gmbh Sp. Z O.O. Oddzial W Polsce (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: G.L. Pharma Gmbh Sp. Z O.O. Oddzial W Polsce Profile Updated: June 20, 2021
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English & Polish Download a sample report

G.L. Pharma Gmbh Sp. Z O.O. Oddzial W Polsce is a company based in Poland, with its head office in Lannach. The company operates in the Pharmaceutical Preparation Manufacturing industry. It was incorporated on January 28, 2010. 20 (2017) employees currently work for G.L. Pharma Gmbh Sp. Z O.O. Oddzial W Polsce. Over the same period, its total assets grew by 3.63%.

Headquarters
Schlossplatz 1
Lannach; Polityczna Gmina Lannach; Postal Code: 8502

Contact Details: Purchase the G.L. Pharma Gmbh Sp. Z O.O. Oddzial W Polsce report to view the information.

Website: http://www.gl-pharma.pl

Basic Information
Total Employees:
Purchase the G.L. Pharma Gmbh Sp. Z O.O. Oddzial W Polsce report to view the information.
Outstanding Shares:
Purchase the G.L. Pharma Gmbh Sp. Z O.O. Oddzial W Polsce report to view the information.
Incorporation Date:
January 28, 2010
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Company Performance
Financial values in the chart are available after G.L. Pharma Gmbh Sp. Z O.O. Oddzial W Polsce report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
-27.43%
Operating profit (EBIT)
12.46%
EBITDA
13.44%
Net Profit (Loss) for the Period
12.47%
Total assets
3.63%
Total equity
16.89%
Return on Equity (ROE)
313.96%
Quick Ratio
0.57%
Cash Ratio
0.55%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?